Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 4,935,600 | 4,683,100 | 5,808,800 | 5,772,600 | 5,929,700 |
| Cost of Goods | 1,189,700 | 1,222,700 | 1,386,500 | 1,198,100 | 1,165,200 |
| Gross Profit | 3,745,900 | 3,460,400 | 4,422,300 | 4,574,500 | 4,764,500 |
| Operating Expenses | 2,860,000 | 2,594,900 | 3,543,699 | 3,029,900 | 3,261,700 |
| Operating Income | 886,600 | 866,200 | 879,100 | 1,544,700 | 1,503,000 |
| Other Income | 53,800 | 24,600 | 30,800 | -31,300 | 11,900 |
| Pre-tax Income | 940,400 | 890,800 | 909,900 | 1,513,400 | 1,514,900 |
| Income Tax | 206,900 | 162,900 | 182,400 | 310,300 | 308,700 |
| Net Income Continuous | 733,500 | 727,900 | 727,500 | 1,203,100 | 1,206,200 |
| Net Income | $733,500 | $727,900 | $727,500 | $1,203,100 | $1,206,200 |
| EPS Basic Total Ops | 0.68 | 0.68 | 0.68 | 1.11 | 1.12 |
| EPS Basic Continuous Ops | 0.68 | 0.68 | 0.68 | 1.11 | 1.12 |
| EPS Diluted Total Ops | 0.68 | 0.68 | 0.68 | 1.11 | 1.11 |
| EPS Diluted Continuous Ops | 0.68 | 0.68 | 0.68 | 1.11 | 1.11 |
| EBITDA(a) | $1,235,000 | $1,215,000 | $1,230,301 | $1,893,700 | $1,866,900 |